NNC-26-9100

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameNNC-26-9100
Drug Alias NameNNC-26-9100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSomatostatin receptor 4 agonists
TargetsSomatostatin receptor 4
Therapy Area/IndicationsGlaucomaOcular Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovo Nordisk A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovo Nordisk A/S
Active IndicationsN/A
Inactive IndicationsGlaucomaOcular Hypertension

Other Information

ATC CodeN/A
Related LinksN/A